Artugen Therapeutics

Developer of microbiome therapeutics to treat infectious and inflammatory diseases

placeConcord, Massachusetts, United States calendar_todayFounded 2018 groups10 employees language artugentherapeutics.com

Innovation

7 patent families (1 granted) — focus: Human necessities; filing pace steady. Cited 191 times.

YearFilings
20191
20212
20221
20234
20245
20251
20261

Investor mix

1 investor on record; lead investors include Morningside.

Investor typeCountShare
Venture capital1100%
Coming soon